Cannabidiol as potential treatment in refractory pediatric epilepsy

Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy

(2015) Alexandra L. Geffrey et al.   EPILEPSIA

Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome

(2015) Shaun A. Hussain et al.   EPILEPSY & BEHAVIOR

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy

(2015) Craig A. Press et al.   EPILEPSY & BEHAVIOR

Pure Cannabidiol in the Treatment of Malignant Migrating Partial Seizures in Infancy: A Case Report

(2015) Dimah Saade et al.   PEDIATRIC NEUROLOGY

Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol

(2015) Felipe V. Gomes et al.   SCHIZOPHRENIA RESEARCH

The case for assessing cannabidiol in epilepsy

(2014) Maria Roberta Cilio et al.   EPILEPSIA

Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: Result ofEpilepsia's survey

(2014) Gary W. Mathern et al.   EPILEPSIA

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

(2014) Orrin Devinsky et al.   EPILEPSIA

Cannabis, cannabidiol, and epilepsy — From receptors to clinical response

(2014) Jerzy P. Szaflarski et al.   EPILEPSY & BEHAVIOR

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology

(2014) B. S. Koppel et al.   NEUROLOGY

Cannabidiol: Promise and Pitfalls

(2014) Timothy E. Welty et al.   Epilepsy Currents

Treatment of Epileptic Encephalopathies

(2013) Amy McTague et al.   CNS DRUGS

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy

(2013) Brenda E. Porter et al.   EPILEPSY & BEHAVIOR

Dare to Delay? The Impacts of Adolescent Alcohol and Marijuana Use Onset on Cognition, Brain Structure, and Function

(2013) Krista M. Lisdahl et al.   Frontiers in Psychiatry

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

(2012) Amir Englund et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

(2012) Nicholas A. Jones et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention

(2011) Mackenzie E. Hofmann et al.   EXPERIMENTAL NEUROLOGY

Temporal characterization of changes in hippocampal cannabinoid CB 1 receptor expression following pilocarpine-induced status epilepticus

(2009) Katherine W. Falenski et al.   BRAIN RESEARCH

Managing Severe Epilepsy Syndromes of Early Childhood

(2009) James W. Wheless   JOURNAL OF CHILD NEUROLOGY

Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels

(2009) D. Ryan et al.   JOURNAL OF NEUROSCIENCE

Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo

(2009) N. A. Jones et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY